NABP Testifies at US House Subcommittee Hearing Regarding Support for Federal Legislation to Distinguish Between Compounding and Manufacturing
NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony (PDF) presented at a United States House subcommittee hearing on May 23, 2013. The hearing, “Examining Drug Compounding” was held to provide US Committee on Energy and Commerce Health Subcommittee members an opportunity to hear testimony from Food and […]
Read More ›Bill To Expand Pharmacists’ Authority to Vaccinate Under Consideration in Pennsylvania Legislature
Pharmacists in Pennsylvania would be granted authority to vaccinate patients above the age of seven with a parent’s consent under two bills being considered by the Pennsylvania General Assembly. The bills would also allow pharmacy interns to vaccinate under the supervision of a pharmacist. The bills, HB 776 and SB 819, are in the professional licensure […]
Read More ›NABP Surveyors to Assist With New Jersey Compounding Pharmacy Inspections Under Contract With the State
Under a contract with the New Jersey Division of Consumer Affairs (Division) and the state’s Attorney General Jeffrey S. Chiesa, NABP will assist the Division with inspections of New Jersey pharmacies engaged in the practice of compounding. The planned pharmacy surveys will expand the Division’s already robust inspections of compounding pharmacies. As noted in a […]
Read More ›New Missouri Law to Grant Board of Pharmacy Authority to Inspect Drugs in Inventory
The Missouri Board of Pharmacy will be allowed to test drugs in pharmacy inventories under a new law just signed by Missouri Governor Jay Nixon. Under the new law, the Board will have the authority to establish a program for testing drugs, including compounded drugs, held by licensees. Board personnel currently may enter and inspect […]
Read More ›NABP Supports Federal Legislation Creating New Category of Manufacturer Under FDA Oversight, While Maintaining Board of Pharmacy Authority Over Compounding Pharmacies
In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution. The Senate Health, Education, Labor, and Pensions (HELP) committee’s proposed legislation distinguishes between pharmacies engaged in […]
Read More ›Sixth DEA Take-Back Day Collects Over 740,000 Pounds of Unneeded Medication, Helping to Prevent Diversion and Abuse
The Drug Enforcement Administration’s (DEA) sixth National Prescription Drug Take-Back Day on April 27, 2013, collected twice the amount of unneeded and expired medications for safe disposal than the previous DEA take-back event six months ago. The level of consumer participation in the event shows the continued need for a means of safe, legal disposal […]
Read More ›Bill to Strengthen Regulation of Compounding Introduced in Maine Legislature
A bill (LD1315) to strengthen the regulation of compounding pharmacies in Maine was introduced to the state’s legislature. The proposed law would require pharmacies compounding medications to obtain a special license, and would require that all pharmacies dispensing compounded drugs to patients in Maine be licensed by the state. The bill also proposes to change […]
Read More ›Teen Prescription Drug Abuse Rates Rising, Attitudes About Stimulant Abuse of Particular Concern
Teen abuse of prescription drugs has increased, in part driven by teens’ and parents’ attitudes toward stimulant abuse, indicates the latest Partnership Attitude Tracking Study. According to the national study, conducted by the Partnership at Drugfree.org, almost one-third of parents report that they believe stimulants such as Ritalin® and Adderall® can improve a child’s academic […]
Read More ›Illegal Online Sellers Fuel Global Spread of Fake and Substandard Medications, International Collaboration Key in Response, Reports NABP
The National Association of Boards of Pharmacy® (NABP®) today issued a report emphasizing that the global distribution of counterfeit and substandard medications, fueled by illegal online sellers, demands an international response. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: April 2013, NABP has partnered with regulatory authorities, […]
Read More ›FDA Reports Unsanitary Conditions at Compounding Facilities, Calls for More Regulatory Authority
FDA Commissioner Margaret A. Hamburg, MD, reported in a recent FDA blog article that agency inspectors encountered “objectionable conditions” at 30 of the 31 sterile compounding pharmacies they recently examined. Some of the conditions they witnessed included black particles floating in vials of supposedly sterile medicine, rust and mold in clean rooms, and technicians handling […]
Read More ›